收费全文 | 145992篇 |
免费 | 7149篇 |
国内免费 | 449篇 |
耳鼻咽喉 | 2055篇 |
儿科学 | 4121篇 |
妇产科学 | 3642篇 |
基础医学 | 19974篇 |
口腔科学 | 4015篇 |
临床医学 | 11320篇 |
内科学 | 32891篇 |
皮肤病学 | 3528篇 |
神经病学 | 12399篇 |
特种医学 | 3799篇 |
外国民族医学 | 2篇 |
外科学 | 18391篇 |
综合类 | 783篇 |
一般理论 | 69篇 |
预防医学 | 14528篇 |
眼科学 | 3013篇 |
药学 | 10662篇 |
1篇 | |
中国医学 | 368篇 |
肿瘤学 | 8029篇 |
2023年 | 828篇 |
2022年 | 830篇 |
2021年 | 2681篇 |
2020年 | 1524篇 |
2019年 | 2804篇 |
2018年 | 4408篇 |
2017年 | 2971篇 |
2016年 | 3064篇 |
2015年 | 3392篇 |
2014年 | 3950篇 |
2013年 | 6127篇 |
2012年 | 9953篇 |
2011年 | 10228篇 |
2010年 | 5550篇 |
2009年 | 4429篇 |
2008年 | 8460篇 |
2007年 | 9076篇 |
2006年 | 8525篇 |
2005年 | 8620篇 |
2004年 | 7927篇 |
2003年 | 7364篇 |
2002年 | 6915篇 |
2001年 | 3550篇 |
2000年 | 3675篇 |
1999年 | 3112篇 |
1998年 | 1004篇 |
1997年 | 722篇 |
1996年 | 710篇 |
1995年 | 580篇 |
1994年 | 493篇 |
1993年 | 462篇 |
1992年 | 1482篇 |
1991年 | 1377篇 |
1990年 | 1282篇 |
1989年 | 1181篇 |
1988年 | 1065篇 |
1987年 | 1050篇 |
1986年 | 992篇 |
1985年 | 994篇 |
1984年 | 760篇 |
1983年 | 622篇 |
1979年 | 701篇 |
1978年 | 461篇 |
1975年 | 453篇 |
1974年 | 607篇 |
1973年 | 552篇 |
1972年 | 473篇 |
1971年 | 433篇 |
1970年 | 495篇 |
1969年 | 447篇 |
Areas covered: We discuss the current understanding of the HH pathway as it relates to normal hematopoiesis, the pathology of acute myeloid leukemia (AML), the rationale for and data from combination therapies including HH pathway inhibitors, and ultimately the prospects that might offer promise in targeting this pathway in AML.
Expert opinion: Efforts to target the HH pathway have been focused on impeding this disposition and restoring chemosensitivity to conventional myeloid neoplasm therapies. The year 2018 saw the first approval of a HH pathway inhibitor (glasdegib) for AML, though for an older population and in combination with an uncommonly-used therapy. Several other clinical trials with agents targeting modulators of HH signaling in AML and MDS are underway. Further study and understanding of the interplay between the numerous aspects of HH signaling and how it relates to the augmented survival of AML will provide a more reliable substrate for therapeutic strategies in patients with this poor-risk disease. 相似文献
Areas covered: This article reviews the major preclinical and clinical data on PDE5 inhibitors with a specific focus on tadalafil. It includes details of the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) – PDE5 pathway in the LUT organs (bladder and prostate) in addition to the available data on tadalafil in patients with LUTS secondary to BPH with or without erectile dysfunction (ED).
Expert opinion: Preclinical and clinical data have clearly demonstrated that PDE5 inhibitors induce bladder and prostate relaxation, which contributes to the improvement seen in storage symptoms in both animal models of bladder and prostate hypercontractility. Tadalafil is effective both as a monotherapy and add-on therapy in patients with LUTS secondary to BPH. Furthermore, as LUTS-BPH and ED are urological disorders that commonly coexist in aging men, tadalafil is more advantageous than α1-adrenoceptors and should be used as the first option. Tadalafil is a safe and tolerable therapy and unlike α1- adrenoceptors and 5-alpha reductase inhibitors, which can cause sexual dysfunctions, tadalafil improves sexual function. 相似文献
Areas covered: This review includes a view of the clinical classification and risk assessment in children suffering from HL. The chemotherapy more commonly employed is revisited. The use of PET/CT to evaluate the disease in order to guide therapy is analyzed. New options of chemotherapy and emerging immunotherapy are also included.
Expert opinion: In order to make the right treatment choice, a proper initial assessment of risk is mandatory. The choice of therapy in these kinds of patients must be done according to the experience of the team, and also, the cost and logistics related to the eligible scheme are very important. If possible, efforts must be made to include PET/CT in guiding therapy and avoiding overtreatment and long-term adverse effects in children. New options in immunotherapy are emerging and must be considered with caution in selected patients. 相似文献